P110 administration was shown to prevent the interaction between Drp1 and Fis1, as well as Drp1 translocation to mitochondria, which reduced mitochondrial fragmentation, and inhibited ALS pathology [49]. Here, FIS1 is linked to amyotrophic lateral sclerosis.